ArticleScientific reports2021

Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model.

Brennan S Dirk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.